Time is a dose of good medicine.
时间是一剂良药。
A dose of flu kept me off work .
一次感冒使我上不了班。
She dosed herself up with vitamin pills.
她给自己服了一些维生素片。
It delivers an adequate dose to the target tumor while sparing healthy tissues and organs at risk around the tumor.
它向靶肿瘤提供足够的剂量，同时保护肿瘤周围处于危险中的健康组织和器官。
With a focus on innovative medicines and the discovery, development, and commercialization of mRNA vaccines, the company said the annual production capacity from the base is expected to reach 700 million doses.
该公司专注于创新药物以及信使核糖核酸疫苗的发现、开发和商业化，表示该基地的年产能预计将达到7亿剂。
By the end of 2021, the company had supplied the world with 3.5 billion doses of COVID-19 vaccines through production both at home and abroad.
截至2021年底，该公司已通过国内外生产向全球供应了35亿剂新冠肺炎疫苗。
By the end of 2021, the company had supplied 3.5 billion doses of COVID-19 vaccines through production at both home and abroad.
截至2021年底，该公司已通过国内外生产供应了35亿剂新冠肺炎疫苗。
Three doses of vaccines will be used, with the first two doses given 28 days apart followed by a third dose at least 3 months after the second dose, and there is no restriction on the application for immunosuppressed children.
将使用三剂疫苗，前两剂间隔28天接种，第二剂接种后至少3个月接种第三剂，免疫抑制儿童的应用没有限制。
The total number of COVID-19 vaccine doses administered on the Chinese mainland was around 3.41 billion as of July 14, data from the National Health Commission showed.
国家卫生健康委员会的数据显示，截至7月14日，中国大陆接种新冠肺炎疫苗的总剂量约为34.1亿剂。
Data from the Ministry of Commerce showed China has provided more than 2.2 billion doses of COVID-19 vaccines to more than 120 countries, regions and international organizations.
商务部的数据显示，中国已向120多个国家、地区和国际组织提供了超过22亿剂新冠肺炎疫苗。
A report from Southwest Securities said nearly 64 percent of the world's population has already been vaccinated with at least one dose of a COVID vaccine, while around 57 percent have been fully inoculated.
西南证券的一份报告称，全球近64%的人口已经接种了至少一剂新冠疫苗，而约57%的人已经完全接种。
This means demand for COVID-19 vaccines for basic inoculation programs will be around 3.3 billion doses globally, while the figure for booster vaccines is expected to be 6.1 billion doses worldwide, the report estimated.
报告估计，这意味着全球基本接种计划对新冠肺炎疫苗的需求将约为33亿剂，而全球加强疫苗的需求预计为61亿剂。
"In total, more than 119 countries, regions and international organizations have approved the use of COVID-19 vaccines made by CNBG, which has produced more than 3 billion doses of such vaccines at home and overseas.
“总共有119多个国家、地区和国际组织批准使用CNBG生产的新冠肺炎疫苗，该公司已在国内外生产了超过30亿剂此类疫苗。
Sinovac, which has been granted access licenses by more than 60 countries, international organizations and regions in total for its COVID-19 vaccine CoronaVac, has supplied more than 2.8 billion doses worldwide.
科兴公司新冠肺炎疫苗CoronaVac已获得60多个国家、国际组织和地区的准入许可，该公司已在全球供应超过28亿剂疫苗。
After completion, the very first vaccine production line with direct involvement of China in the UAE will play a key role in delivering COVID-19 vaccines in the Middle East and North Africa, with its annual capacity reaching 200 million doses per year, said its builder－the China State Construction Engineering Corp Middle East.
阿联酋第一条由中国直接参与的疫苗生产线建成后，将在中东和北非提供新冠肺炎疫苗方面发挥关键作用，其年产能将达到每年2亿剂。
According to a report in the People's Daily, till June, China has provided more than 2.2 billion doses of COVID-19 vaccines to more than 120 countries and international organizations, and has successively transferred vaccine-related technology to, or cooperated in vaccine production with, more than 20 countries, forming an overseas annual production capacity of 1 billion doses.
据《人民日报》报道，截至6月，中国已向120多个国家和国际组织提供超过22亿剂新冠肺炎疫苗，并先后向20多个国家转让或合作疫苗相关技术，形成了10亿剂的海外年生产能力。
Half of them will receive one or two doses of the Sinovac vaccine, while the other half will receive a different quadrivalent influenza vaccine commercially available in Chile.
其中一半将接种一剂或两剂科兴疫苗，另一半将接种在智利上市的不同四价流感疫苗。
So far, its cargo unit has transported more than 600 million doses of COVID-19 vaccines throughout the pandemic.
到目前为止，其货运部门已在整个疫情期间运输了超过6亿剂新冠肺炎疫苗。
Once complete, the first phase of manufacturing will be dedicated to PTX-COVID19-B, with an expected annual capacity of 700-800 million doses.
一旦完成，第一阶段的生产将专门用于PTX-COVID19-B，预计年产能为7-8000万剂。
With the advanced freight handling system in Hong Kong, it has transferred about 76 million doses of COVID-19 vaccines to overseas markets with its freighters.
凭借香港先进的货运系统，该公司已通过货船向海外市场转运了约7600万剂新冠肺炎疫苗。
State drugmaker provided more than 2.5b doses to 112 regions, world bodiesThe world's first COVID-19 vaccine developed by State-owned drugmaker Sinopharm marked the first anniversary of its registration and its launch in the market on Thursday.
国有制药商向112个地区和世界机构提供了超过25亿剂疫苗。由国有制药商国药集团开发的全球首款新冠肺炎疫苗于周四庆祝其注册并上市一周年。
Sinopharm has provided more than 2.5 billion doses of COVID-19 vaccines to China and overseas markets, the company said.
该公司表示，国药集团已向中国和海外市场提供超过25亿剂新冠肺炎疫苗。
The company has built six production plants and three labs in China, and the annual vaccine production capacity has exceeded 7 billion doses.
该公司在中国建立了六个生产工厂和三个实验室，年疫苗生产能力已超过70亿剂。
So far, Sinopharm has provided 2.5 billion doses of COVID-19 vaccines to China and overseas markets, and nearly 1 billion doses have been provided to more than 100 countries.
截至目前，国药集团已向中国和海外市场提供了25亿剂新冠肺炎疫苗，并向100多个国家提供了近10亿剂。
Its annual production capacity has reached nearly 7 billion doses.
其年生产能力已达到近70亿剂。
Agfa's Smart XR portfolio provides DR tools for dose, alignment, patient positioning and more to support enhanced clinical and operational performance while leaving the radiographer in control.
During the CIIE, Novartis will display some cutting-edge therapies not yet marketed in China, including a first-in-class small interfering RNA－ribonucleic acid－cholesterol-lowering treatment with only two doses a year.
As of April, it had transported nearly 20 million doses of vaccines to 24 countries.
As of September, the carrier transported nearly 250 million doses of vaccines to more than 80 destinations globally.
Of that total, 40 million vaccine doses were exported from Beijing.
According to an advance purchase agreement with Gavi, or the Vaccine Alliance, the company will provide up to 414 million doses of its protein-based COVID-19 vaccine candidate for procurement through the COVAX facility.
Bangladesh will be able to produce 5 million doses of Sinopharm's inactivated COVID-19 vaccines monthly, according to a memorandum of understanding signed virtually from Beijing and Dhaka on Monday.
Sinopharm has so far provided more than 13.5 million doses of COVID-19 vaccines to Bangladesh through the COVAX facility, charity and government assistance programs and commercial purchases.
China plans to provide a total of 2 billion doses of COVID-19 vaccines to the world this year, in the latest effort to honor its commitment to make vaccines a global public good by ensuring vaccine accessibility and affordability.
Shanghai-based Fosun Pharmaceutical Group has signed agreements with Taiwan-based Foxconn, the Taiwan Semiconductor Manufacturing Co, and a charity foundation to provide 10 million doses of mRNA COVID-19 vaccines during a major shortage on the island, the company said on Sunday.
Clover continues to plan to commence product launch of SCB-2019 (CpG 1018/Alum) by the end of 2021 and recently signed an advance purchase agreement with the Global Alliance for Vaccines and Immunization, committing up to 414 million doses to the COVAX facility.
Clover also expects to supply doses to countries directly via government procurement and/or bilateral supply agreements.
The agreement includes doses for delivery in 2021, which were manufactured under the previously announced funding agreement between the Coalition for Epidemic Preparedness Innovations and Dynavax.
Clover separately announced on Wednesday an advanced purchase agreement with Gavi, the Vaccine Alliance, for supplying up to 414 million doses of SCB-2019 (CpG 1018/Alum) through 2022 for the COVAX facility.
According to the agreement, the company is to provide up to 414 million doses of its protein-based COVID-19 vaccine candidate for procurement through the COVAX facility.
Pending an Emergency Use Listing from the World Health Organization for Clover's COVID-19 vaccine candidate, Clover will make an initial 64 million doses available for procurement through the COVAX facility in 2021.
Gavi also retains options to procure up to an additional 350 million doses to be delivered in 2022.
In exchange for these commitments, Clover will receive a significant upfront payment, a payment upon positive Phase-2/3 data, and additional advance payments upon Gavi's exercise of options for doses to be delivered in 2022.
Gavi will allocate Clover's COVID-19 vaccine doses to the AMC (Advanced Market Commitment)-eligible and self-financing participants under a tiered pricing plan.
Clover will further receive additional payments upon the delivery of the doses of its COVID-19 vaccine at all pricing tiers, including doses being delivered to the AMC-eligible participants.
Fosun Pharmaceutical Industrial shall provide a manufacturing facility, which has a potential capacity of producing up to 1 billion doses of coronavirus vaccine products every year, according to the announcement.
By March this year, BioNTech had delivered more than 200 million doses of mRNA-based COVID-19 vaccines to more than 65 countries and regions, according to the company's earnings report released in late March.
BioNTech and Pfizer have signed orders of 1.4 billion doses for delivery this year.
Monofer provides the opportunity to infuse a single dose of 1,000 mg iron from 15 to more than 30 minutes, reducing the duration of a session of IV iron treatment from hours to less than an hour.
Chinese pharmaceutical company Sinovac Biotech Ltd will donate a total of 50,000 doses of its COVID-19 vaccines to the South American Football Confederation, as the Copa América 2021 Argentina-Colombia will be held between June and July.
The latest peer-reviewed study from RLX Technology (RELX) published in the Journal of Applied Toxicology showed the cooling agent WS-23 widely used in e-cigarettes has limited impact on experimental animals at the tested dose.
The study shows that at the tested dose level, inhalation of WS-23 will not bring toxic side effects to animals.
Clover expects to initiate a global Phase 2/3 efficacy trial for SCB-2019 (S-Trimer), its COVID-19 vaccine candidate, in the first half of 2021 and has initiated production planning for potentially hundreds of millions of vaccine doses in 2021.
Now the company churns out about 400,000 doses a day.
"The yearly output of our first production line has reached 500 million doses.
Our second production line started operations this month, enabling the company to attain capacity to produce 1 billion doses of vaccine every year," said Yin Weidong, chairman of Nasdaq-listed Sinovac.
Two batches of nearly 4 million vaccine doses were delivered to the country on Jan 28 and Jan 31.
The vaccine candidates, such as the messenger ribonucleic acid (mRNA) vaccine developed by US-based Pfizer and the recombination vaccine developed by UK-based AstraZeneca, had received orders for more than 1 billion doses overseas.
The biotech company, one of two federally authorized makers of coronavirus vaccines, said Monday it wants the Food and Drug Administration (FDA) to allow it to add up to 50 percent — five additional doses — of its vaccine in each vial.
If evidence shows it's effective, and the request is approved, it could significantly increase the number of doses available to the public in a few weeks.
"The company is proposing filling vials with additional doses of vaccine, up to 15 doses versus the current 10 doses," Moderna President Stephen Hoge told Reuters.
Both Pfizer's and Moderna's vaccines require two doses.
The company said it quickly realized that filling small vials with tiny doses of vaccine was slowing it down.
But tests showed that too many doses in one vial could break it.
The drugmaker aims to deliver 100 million doses to the US government by the end of March and 100 million more by the end of June.
Moderna said on Jan 27 that it had held talks with the US government on the possibility of delivering another 100 million doses, which would bring the total to 300 million.
As of Monday morning, the US Centers for Disease Control and Prevention (CDC) had administered 42.4 million doses of coronavirus vaccines.
It has administered 160,000 doses to date.
The federal government will send a million doses of the vaccines to 6,500 pharmacies on Feb 11.
But its vaccine may contribute only 7 million doses by April.
By Jan 20, more than 15 million doses had been administered.
Sinovac Biotech Ltd will double annual capacity of its CoronaVac vaccine production to 1 billion doses by next month, said its top official.
"The yearly output of our first production line at the company's base in Daxing district of Beijing has reached 500 million doses.
After the second production line starts operations in February, we will be able to produce 1 billion doses of vaccine every year," said Yin Weidong, chairman of Sinovac, a Beijing-based, Nasdaq-listed, private-sector company.
By Jan 13, more than 10 million doses have been administered.
According to Sinovac, by Jan 10, it had supplied more than 7 million doses of its vaccine to provinces and municipalities across China.
The Washington Post reported Monday that Pfizer has told the Trump administration it can't provide substantial additional doses of its vaccine until late June or July because other countries have bought up most of its supply, according to multiple individuals familiar with the situation.
Pfizer officials had urged the US to initially purchase 200 million doses, or enough for its two-shot regimen for 100 million people last summer, according to people knowledgeable about the issue who spoke on the condition of anonymity because they weren't authorized to discuss the situation.
But officials declined, choosing instead for 100 million doses, or enough for 50 million people, they said.
Doses are scheduled to be delivered to hospitals beginning Monday.
Bloomberg reported Monday that a spokesperson for the US Department of Health and Human Services (HHS) said states have used outdated federal estimates showing many more doses of Pfizer's vaccine would be available for the initial flow of shots.
Estimates given to states in October for planning purposes said there could be 20 million doses of the Pfizer-BioNTech SE vaccine available and 15 million doses of Moderna's vaccine, according to the spokesperson, who asked not to be identified by name in an emailed response, Bloomberg reported.
But more recently, federal officials have said that 6.4 million doses of the Pfizer vaccine and 12.5 million doses of the Moderna shots will be available in the first shipments.
xa0xa0In China,xa0the phase I/II trials were conducted with results showing the vaccine candidate can induce neutralizing antibodies among over 90 percent of volunteers who received two doses of vaccination in both adults and the elderly.
Sinovac expects to be able to manufacture 300 million doses annually and aims to complete the construction of a second production facility by the end of 2020 to increase the annual production capacity of CoronaVac to 600 million doses.
Zheng Zhongwei, an official from China's National Health Commission, said the nation's annual COVID-19 vaccine production capacity could reach 610 million doses this year and will expand further next year.
CNBG said it has completed building high-level biosafety production bases with capacity totaling more than 1 billion doses for production next year to meet widespread vaccination demand.
He added that the company already has annual production capacity of 300 million doses.
The company and the coalition are committed to ensuring equitable global access to the S-Trimer vaccine, and the agreement anticipates vaccine output funded by the coalition's investment – potentially hundreds of millions of doses per year – will be available for procurement and allocation through the COVAX Facility, which is a global initiative that aims to procure and fairly distribute 2 billion doses of COVID-19 vaccine by the end of 2021, to help protect the most at-risk groups in all participating countries.
In parallel to the clinical development process, the program will continue scaling up the manufacturing process to potentially allow the production of more than 1 billion doses annually, and build up vaccine inventory which – if the vaccine is proven to be safe and effective –could be deployed rapidly upon licensure, the company said.
The group's inactivated vaccine is among the world's first batch to acquire clinical trial approval, and the results collected are the world's first clinical data on safety and effectiveness after two doses of vaccination, offering scientific and measurable support for epidemic prevention and control and emergency use, industry insiders said.
Phase-2 explores the vaccine procedure and dose while evaluating safety and efficacy.
In the 18-to-59-year-old age group, those who got two doses of vaccine based on the 0-and-28-day procedure demonstrated 100 percent antibody positive conversion rate, while those who got two doses based on the 0-and-14-day procedure and 0-and-21-day procedure showed a 97.6 percent antibody positive conversion rate.
Industry experts said the results were the world's first clinical data on safety and effectiveness collected after two doses of vaccination, offering scientific and measurable support for epidemic prevention and control and emergency use.
The company said the drug uses an advanced controlled-release mechanism to release the metformin over a controlled period to ensure stable drug effect, so that patients only need to take one dose a day, which can help avoid gastrointestinal adverse reactions and missed medication doses.
Walvax Biotechnology expects to release about 1 million doses of the vaccine during the first half of this year, as amounts following releases will gradually grow, Beijing News reported.
Sinopharm has been exporting such vaccines to India for 12 years, and supplied 2.1 million doses of free vaccines in early 2018, when shortages raised concerns of an outbreak of JE.
The company estimates it will have provided 410 million doses of JE vaccines to India by this year-end.
Its subsidiary for vaccine and biological medicine sector, China National Biotech Group Co Ltd, said more than 450 million doses of the JE vaccine have been exported to 12 countries and regions since receiving the World Health Organization's pre-qualification in October 2013.
Compared with conventional radiotherapy, proton beams will only release a large percentage of radiation dose when they reach a tumor, which means it will kill the cancer cells while leaving healthy cells intact, according to Zhang.
The world's first high-field magnetic resonance-guided linear accelerator－a new radiation therapy system that can locate tumors precisely, tailor the shape of X-ray beams in real time, and adapt radiation doses even to moving tumors while a patient is being treated－will make its debut at the upcoming first China International Import Expo.
The machine will be very appealing to the fast-growing precision and personalized cancer care market in China, because it can deliver doses of radiation more precisely and effectively, and reduce the number of treatment sessions, on the basis of its clear and real-time visualization of tumors and healthy tissues, especially when tumors happen in the brain, spine and abdomen, and because other medical imaging methods, such as CT scans, cannot deliver clear pictures distinguishing tumors and healthy soft-tissues, according to Hausmann.
Over the past three years, China has provided over 2.2 billion doses of COVID-19 vaccine to more than 120 countries and international organizations, and batches of protective suits, ventilators, masks and other supplies to 153 countries and 15 international organizations.